Cardiovascular Disease
News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
BioMed X Barbados Project to Molecularly Characterize Cardiometabolic Disease
The initiative seeks to improve treatments for cardiometabolic disorders among individuals of African descent, beginning with a pilot study of 1,000 people.
A Phase III trial evaluating nex-z in transthyretin amyloidosis with cardiomyopathy is underway, with plans for another focused on polyneuropathy.
University of Helsinki Spinout Developing Blood Test to Tailor Treatment For High Cholesterol
Premium
Moncyte Health's test evaluates biological differences in how cholesterol is transported and processed in cells, which can influence drug response.
Roche Lipoprotein (a) Test Receives FDA 510(k) Clearance
The test, which is intended for assessing cardiovascular risk, is the first lipoprotein (a), or Lp(a), test measured in nanomoles per liter to receive FDA clearance.
In Brief This Week: Qiagen, Care Access, Immix Biopharma, Atsena Therapeutics, Aspen Neuroscience
News items for the week of Jan. 6, 2025.